BlueWillow Biologics, a clinical-stage biopharmaceutical company based in Ann Arbor, Michigan, specializes in the development of intranasal vaccines and anti-infective products utilizing its patented nanotechnology platform. The company's innovative NanoStat vaccine technology incorporates a unique oil-in-water nanoemulsion, allowing for the effective delivery and adjuvant of various antigens. BlueWillow focuses on vaccines for respiratory and sexually transmitted diseases, including pertussis, pandemic influenza, anthrax, and HIV, as well as providing NanoBio Protect, a nasal antiseptic solution. The company also has a licensing agreement with Merck for the use of its adjuvant in intranasal vaccines for respiratory syncytial virus (RSV) and seasonal influenza. Founded in 1999 as a spin-off from the University of Michigan, BlueWillow Biologics aims to enhance mucosal immunity through its advanced vaccine technology.
Metamark Genetics, Inc. is a life science company focused on developing prognostic and predictive diagnostic tests to facilitate personalized treatment planning for cancer patients. Founded in November 2007, the company aims to transform cancer diagnosis and treatment with its Prognosis Determinants™ Platform, which is based on pioneering research in melanoma. These Prognosis Determinants™ are functionally validated genetic elements that play a crucial role in cancer progression across various major cancer types, particularly those that drive metastasis and correlate with poor outcomes. The company's advanced proteomics platform enhances the diagnostic and therapeutic journey for prostate cancer patients by providing sensitive and accurate predictions of progression risk at early disease stages. This technology addresses tumor heterogeneity and enables fully automated, digitalized tissue analyses, allowing patients and their healthcare providers to make informed treatment decisions that improve quality of life and reduce healthcare costs.
CeNeRx BioPharma, Inc., a drug development company, engages in identifying, developing, and commercializing therapeutics to treat diseases related to neurotransmitters and the nervous system. The company's product pipeline includes Tyrima, CX2614, and CX009, which are reversible inhibitors of monoamine oxidase- A that are used for the treatment of mood, anxiety, and somatic disorders. It focuses on developing therapeutics to treat diseases related to neurotransmitters, including anxiety, bipolar disorder, dementia, depression, epilepsy, neuropathic pain, schizophrenia, and Parkinson's and Alzheimer's diseases. The company was founded in 2005 and is based in Cary, North Carolina.
Cymbet develops market eco-friendly, biocompatible rechargeable solid state batteries that provide electronic systems designers with new embedded power capabilities. Cymbet’s EnerChip batteries allow new concepts in energy storage application for ICs and new products for medical, sensor, RFID, industrial control, communications, and portable electronic devices. Their new single chip Power Management Real-Time Clock (PMRTC) device is a world class device and among the lowest power RTCs in the industry.
Lumexis Corporation engages in developing, manufacturing, and marketing fiber-to-the-screen (FTTS) in-flight entertainment (IFE) and communication systems. The company also provides customer support, training, and software services. Lumexis Corporation was founded in 2003 and is based in Costa Mesa, California.
BlueWillow Biologics, a clinical-stage biopharmaceutical company based in Ann Arbor, Michigan, specializes in the development of intranasal vaccines and anti-infective products utilizing its patented nanotechnology platform. The company's innovative NanoStat vaccine technology incorporates a unique oil-in-water nanoemulsion, allowing for the effective delivery and adjuvant of various antigens. BlueWillow focuses on vaccines for respiratory and sexually transmitted diseases, including pertussis, pandemic influenza, anthrax, and HIV, as well as providing NanoBio Protect, a nasal antiseptic solution. The company also has a licensing agreement with Merck for the use of its adjuvant in intranasal vaccines for respiratory syncytial virus (RSV) and seasonal influenza. Founded in 1999 as a spin-off from the University of Michigan, BlueWillow Biologics aims to enhance mucosal immunity through its advanced vaccine technology.
BlueWillow Biologics, a clinical-stage biopharmaceutical company based in Ann Arbor, Michigan, specializes in the development of intranasal vaccines and anti-infective products utilizing its patented nanotechnology platform. The company's innovative NanoStat vaccine technology incorporates a unique oil-in-water nanoemulsion, allowing for the effective delivery and adjuvant of various antigens. BlueWillow focuses on vaccines for respiratory and sexually transmitted diseases, including pertussis, pandemic influenza, anthrax, and HIV, as well as providing NanoBio Protect, a nasal antiseptic solution. The company also has a licensing agreement with Merck for the use of its adjuvant in intranasal vaccines for respiratory syncytial virus (RSV) and seasonal influenza. Founded in 1999 as a spin-off from the University of Michigan, BlueWillow Biologics aims to enhance mucosal immunity through its advanced vaccine technology.
SoftSwitching Technologies specializes in power quality and monitoring solutions tailored for industries such as semiconductor, food, beverage, and automotive. The company provides a range of products, including battery-free DySC systems, intelligent I-Sense sensors that detect the timing and duration of voltage sags, and Grid Alert event notifications, which are part of a global power reporting network. Their offerings are designed to identify and mitigate brief power disruptions, thereby enhancing operational uptime and efficiency in manufacturing processes. Overall, SoftSwitching Technologies aims to deliver effective and scalable solutions that address the critical power quality needs of various sectors.
Private Equity Round in 2008
VPG is working with General Motors through its on-highway integrator Powertrain Integration LLC. Marketing, technical, and infra-structure logistical support for the CNG model will be provided by Clean Energy Fuels Corp., founded by T. Boone Pickens, both of whom are also investors in VPG. The vehicle will be assembled by AM General LLC, in Mishawaka, Indiana, and will employ a classic front-engine, rear-wheel drive architecture which includes a durable body-on-frame structure. Vehicle access is compliant with the vehicle requirements of the Americans with Disabilities Act ("ADA"). The vehicle includes an integrated automatic ramp that will provide quick and easy access for individuals who use wheelchairs, motorized scooters and other mobility devices. Originally introduced as the "Standard Taxi", VPG's vehicle has undergone design and functional enhancements based on input from the marketplace.
Bioenvision a biopharmaceutical company, engages in the acquisition, development, and marketing of compounds and technologies primarily for the treatment of cancer. Its lead products include Evoltra (clofarabine) which has marketing approval in both the European Union and United States for the treatment of pediatric relapsed or refractory acute lymphoblastic leukemia and Modrenal (trilostane), which has marketing approval in the United Kingdom for the treatment of post-menopausal breast cancer following relapse to initial hormone therapy.
Ascenta Therapeutics is a privately-held, clinical stage biopharmaceutical company dedicated to the discovery and development of new medicines to treat cancer. Ascenta's current focus is a portfolio of novel, orally-active, small molecule drugs that restore the natural potential for cancer cells to undergo cell death (apoptosis).
MAP Pharmaceuticals, Inc., a development stage company, focuses on developing novel inhalation therapies for respiratory and systemic diseases. It has various proprietary product candidates in clinical development, including Unit Dose Budesonide for pediatric asthma in children from six months to eight years of age and MAP0004 for migraine. The company's product portfolio also includes MAP0005 for the treatment of adolescent and adult asthma, and chronic obstructive pulmonary disease; and MAP0001 for the treatment of Type 1 and Type 2 diabetes via pulmonary delivery using its Tempo inhaler. MAP Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Mountain View, California.
Serveron Corporation is a developer of online transformer products and diagnostic services, headquartered in Hillsboro, Oregon. The company specializes in transformer monitors that deliver essential asset data, including dissolved gas analysis of insulating oil in power transformers and other oil-filled equipment. Serveron’s offerings include monitoring services that allow access to transformer data from any Internet-connected Windows personal computer, transformer bushing monitors for power factor testing, and advisory services to help utilities manage their transformer fleets effectively. Additionally, the company provides energy asset management solutions for remote energy systems, enabling real-time monitoring, control, and reporting. Serveron serves a diverse clientele that includes utilities, industrial users, and service organizations both in the United States and internationally. The company was previously known as Micromonitors, Inc. and is currently a subsidiary of BPL Global, Ltd.
BlueWillow Biologics, a clinical-stage biopharmaceutical company based in Ann Arbor, Michigan, specializes in the development of intranasal vaccines and anti-infective products utilizing its patented nanotechnology platform. The company's innovative NanoStat vaccine technology incorporates a unique oil-in-water nanoemulsion, allowing for the effective delivery and adjuvant of various antigens. BlueWillow focuses on vaccines for respiratory and sexually transmitted diseases, including pertussis, pandemic influenza, anthrax, and HIV, as well as providing NanoBio Protect, a nasal antiseptic solution. The company also has a licensing agreement with Merck for the use of its adjuvant in intranasal vaccines for respiratory syncytial virus (RSV) and seasonal influenza. Founded in 1999 as a spin-off from the University of Michigan, BlueWillow Biologics aims to enhance mucosal immunity through its advanced vaccine technology.
MAP Pharmaceuticals, Inc., a development stage company, focuses on developing novel inhalation therapies for respiratory and systemic diseases. It has various proprietary product candidates in clinical development, including Unit Dose Budesonide for pediatric asthma in children from six months to eight years of age and MAP0004 for migraine. The company's product portfolio also includes MAP0005 for the treatment of adolescent and adult asthma, and chronic obstructive pulmonary disease; and MAP0001 for the treatment of Type 1 and Type 2 diabetes via pulmonary delivery using its Tempo inhaler. MAP Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Mountain View, California.
Serveron Corporation is a developer of online transformer products and diagnostic services, headquartered in Hillsboro, Oregon. The company specializes in transformer monitors that deliver essential asset data, including dissolved gas analysis of insulating oil in power transformers and other oil-filled equipment. Serveron’s offerings include monitoring services that allow access to transformer data from any Internet-connected Windows personal computer, transformer bushing monitors for power factor testing, and advisory services to help utilities manage their transformer fleets effectively. Additionally, the company provides energy asset management solutions for remote energy systems, enabling real-time monitoring, control, and reporting. Serveron serves a diverse clientele that includes utilities, industrial users, and service organizations both in the United States and internationally. The company was previously known as Micromonitors, Inc. and is currently a subsidiary of BPL Global, Ltd.
Iridian Technologies, Inc. specializes in the research, development, and marketing of biometric identification solutions, focusing primarily on iris recognition technology. The company offers PrivateID, an image processing protocol that enables certified iris cameras to capture and process images for secure transport. Additionally, it provides the KnoWho authentication server and related developer tools, along with hardware and software certification programs. Iridian's products are designed to enhance security in various public applications, including passenger travel, border control, national identification, and election verification. The company distributes its authentication server software through integrators and application partners, catering to sectors that require reliable identity verification. Founded in 1990 and based in Moorestown, New Jersey, Iridian Technologies was previously known as IriScan, Inc. before rebranding in 2000.
Serveron Corporation is a developer of online transformer products and diagnostic services, headquartered in Hillsboro, Oregon. The company specializes in transformer monitors that deliver essential asset data, including dissolved gas analysis of insulating oil in power transformers and other oil-filled equipment. Serveron’s offerings include monitoring services that allow access to transformer data from any Internet-connected Windows personal computer, transformer bushing monitors for power factor testing, and advisory services to help utilities manage their transformer fleets effectively. Additionally, the company provides energy asset management solutions for remote energy systems, enabling real-time monitoring, control, and reporting. Serveron serves a diverse clientele that includes utilities, industrial users, and service organizations both in the United States and internationally. The company was previously known as Micromonitors, Inc. and is currently a subsidiary of BPL Global, Ltd.
Serveron Corporation is a developer of online transformer products and diagnostic services, headquartered in Hillsboro, Oregon. The company specializes in transformer monitors that deliver essential asset data, including dissolved gas analysis of insulating oil in power transformers and other oil-filled equipment. Serveron’s offerings include monitoring services that allow access to transformer data from any Internet-connected Windows personal computer, transformer bushing monitors for power factor testing, and advisory services to help utilities manage their transformer fleets effectively. Additionally, the company provides energy asset management solutions for remote energy systems, enabling real-time monitoring, control, and reporting. Serveron serves a diverse clientele that includes utilities, industrial users, and service organizations both in the United States and internationally. The company was previously known as Micromonitors, Inc. and is currently a subsidiary of BPL Global, Ltd.
Evergreen Solar, Inc. develops, manufactures and markets STRING RIBBONâ„¢ solar power products using its proprietary, low-cost wafer technology. The company's patented wafer manufacturing technology uses significantly less polysilicon than conventional processes. Evergreen Solar's products provide reliable and environmentally clean electric power for residential and commercial applications globally.
SoftSwitching Technologies specializes in power quality and monitoring solutions tailored for industries such as semiconductor, food, beverage, and automotive. The company provides a range of products, including battery-free DySC systems, intelligent I-Sense sensors that detect the timing and duration of voltage sags, and Grid Alert event notifications, which are part of a global power reporting network. Their offerings are designed to identify and mitigate brief power disruptions, thereby enhancing operational uptime and efficiency in manufacturing processes. Overall, SoftSwitching Technologies aims to deliver effective and scalable solutions that address the critical power quality needs of various sectors.
As the vanguard of distributed energy control, Encorp leverages the power of its advanced Gold Box™ to harness diverse forms of generation in today's New Energy Economy. Their energy-tech offerings and grid interconnection expertise advance energy savings, security and efficiency for federal, institutional and commercial installations. Their technologies transform the electric grid into a system that is cleaner, more cost effective, efficient, flexible, reliable, resilient and responsive. Encorp's elegant software and hardware seamlessly integrate a variety of distributed power resources, such as engine-generator sets, microturbines, fuel cells, combined heat and power (CHP or cogeneration), and energy storage devices. These power resources are critical in the operation of any enterprise that demands high-quality, reliable power at reasonable and predictable costs.
Biometric Access Company (BAC) provides innovative yet practical system solutions that improve data management and transaction processing. Optional ID verification is available through our advanced biometric technologies. BAC is committed to price/performance leadership and the development of superior hardware, software and total system solutions that offer an outstanding return on investment to our customers. As the sole proprietor of our SecureTouch® products, BAC designs, develops, manufactures and markets several hardware and software applications to provide complete user solutions.
Serveron Corporation is a developer of online transformer products and diagnostic services, headquartered in Hillsboro, Oregon. The company specializes in transformer monitors that deliver essential asset data, including dissolved gas analysis of insulating oil in power transformers and other oil-filled equipment. Serveron’s offerings include monitoring services that allow access to transformer data from any Internet-connected Windows personal computer, transformer bushing monitors for power factor testing, and advisory services to help utilities manage their transformer fleets effectively. Additionally, the company provides energy asset management solutions for remote energy systems, enabling real-time monitoring, control, and reporting. Serveron serves a diverse clientele that includes utilities, industrial users, and service organizations both in the United States and internationally. The company was previously known as Micromonitors, Inc. and is currently a subsidiary of BPL Global, Ltd.
ClubMom is a free national membership organization for mothers. It was founded in 1999 and is headquartered in New York.